Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Association of MHC-II, PD-L1, and FoxP3 with Disease Status and Outcomes in Patients with Hodgkin Lymphoma

Santosha A. Vardhana, MD PhD, Neval Ozkaya, MD, Eri Matsuki, MD PhD MPH, Janine D. Pichardo, BS, Alison J. Moskowitz, MD, David J Straus, MD, Amanda R Copeland, RN, MSN, CNS, Ai Ni, PhD, Achim A Jungbluth, MD, Craig H Moskowitz, MD, Ahmet Dogan, MD PhD, Anas Younes, MD

Blood (2016) 128 (22): 1774.

https://doi.org/10.1182/blood.V128.22.1774.1774

Published: 2016

Journal Articles

Distinctive Genomic Alterations in Testicular Diffuse Large B Cell Lymphoma

Connie Batlevi, MD PhD, Franck Rapaport, PhD, Lu Wang, MD PhD, Andrew M. Intlekofer, MD PhD, Amanda R. Copeland, RN, MSN, CNS, Achim A Jungbluth, MD, Anne Reiner, MPH, Janine D. Pichardo, BS, Meighan Gallagher, MA, Nancy Bouvier, BS, Nicholas D. Socci, PhD, Frederick Criscuolo, PhD, Nikolaus Schultz, PhD, Maria Arcila, MD, Michael Berger, PhD, Andrew D Zelenetz, MD PhD, Venkatraman E Seshan, PhD, Ahmet Dogan, MD PhD, Anas Younes, MD

Blood (2015) 126 (23): 3655.

https://doi.org/10.1182/blood.V126.23.3655.3655

Published: 2015

Journal Articles

Wilms´Tumor 1 Protein Is Highly Expressed on Malignant Plasma Cells and Provides a Novel Target for Immunotherapeutic Approaches

Guenther Koehne, MDPhD, Satyajit Kosuri, MD, Ekaterina Doubrovina, MD PhD, Tao Dao, PhD, Andrew Scott, Achim A Jungbluth, MD, Richard J O'Reilly, MD

Blood (2015) 126 (23): 98.

https://doi.org/10.1182/blood.V126.23.98.98

Published: 2015

Journal Articles

Recombinant (rec) MAGE-A3 Protein Immunotherapy and Peripheral Blood Lymphocyte (PBL) Reconstitution Induce Strong Antigen-Specific Humoral and Cellular Immune Responses in Patients Undergoing Autologous Stem Cell Transplantation (ASCT) for Consolidation of Multiple Myeloma (MM)

Adam D. Cohen, MD, Nikoletta Lendvai, MDPhD, Sacha Gnjatic, PhD, Achim A Jungbluth, MD, Stephane Bertolini, Linda Pan, Pharm.D., Ralph Venhaus, Ioanna Tsakos, Katarzyna Garcia, MS, Linda Thibodeau, RN, Katherine Alpaugh, PhD, Nailah Cummings, Rafik Fellague-Chebra, MD, Olivier Gruselle, Hearn J. Cho, MD PhD

Blood (2014) 124 (21): 1184.

https://doi.org/10.1182/blood.V124.21.1184.1184

Published: 2014

Journal Articles

MAGE-A3 Recombinant Protein (recMAGE-A3) Immunotherapy and Autologous Peripheral Blood Lymphocyte (PBL) Infusion Is Safe and Induces Robust Humoral Immune Responses In Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplantation (autoSCT)

Adam D Cohen, MD, Nikoletta Lendvai, MD PhD, Sacha Gnjatic, Ph.D., Achim A Jungbluth, MD, Stephane Bertolini, Linda Pan, Pharm.D., Ralph Venhaus, Ioanna Tsakos, Katarzyna Garcia, MS, Linda Thibodeau, RN, Katherine Alpaugh, PhD, Nailah Cummings, Rafik Fellague-Chebra, MD, Olivier Gruselle, Hearn J. Cho, MD, PhD

Blood (2013) 122 (21): 154.

https://doi.org/10.1182/blood.V122.21.154.154

Published: 2013

Journal Articles

WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell–depleted hematopoietic stem cell transplantation and donor lymphocyte infusions

Eleanor M. Tyler, Achim A. Jungbluth, Richard J. O'Reilly, Guenther Koehne

Blood (2013) 121 (2): 308–317.

https://doi.org/10.1182/blood-2012-06-435040

Published: 2013

Includes: Supplemental data

Journal Articles

WT1-Specific Immune Responses in Patients with High-Risk Multiple Myeloma Undergoing Allogeneic T Cell-Depleted Hematopoietic Stem Cell Transplantation Followed by Donor Lymphocyte Infusions

Eleanor Tyler, Achim A Jungbluth, MD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD

Blood (2011) 118 (21): 1993.

https://doi.org/10.1182/blood.V118.21.1993.1993

Published: 2011

Journal Articles

Cancer-Testis (CT) Antigen Expression In AL Amyloidosis

Michael A. Rosenzweig, MD, Heather Landau, MD, Achim A Jungbluth, MD, Nicole Hanson, BSc, Denise Frosina, BSc, Maria Arcila, MD, Raymond L. Comenzo, MD, Guenther Koehne, MD, PhD

Blood (2010) 116 (21): 4055.

https://doi.org/10.1182/blood.V116.21.4055.4055

Published: 2010

Journal Articles

MAGE-A Inhibits Apoptosis In Proliferating Multiple Myeloma Cells

Tricia Nardiello, BA, Achim A Jungbluth, MD, Anna Mei, BA, Maurizio DiLiberto, PhD, Xiangao Huang, PhD, Scott A Ely, MD, MPH, Ruben Niesvizky, MD, Morton Coleman, MD, Roger N Pearse, MD, PhD, David Jayabalan, B.S.M.S, Lloyd J Old, MD, Selina Chen-Kiang, PhD, Hearn J. Cho, MD, PhD

Blood (2010) 116 (21): 785.

https://doi.org/10.1182/blood.V116.21.785.785

Published: 2010

Journal Articles

Expression of Cancer Testis (CT) Antigens NY-ESO-1 and LAGE-1 in Multiple Myeloma (MM): Could a Vaccine against the Former Antigen Be Effective against the Latter?

Bruno Karia, Fabricio de Carvalho, Valéria C.C. Andrade, Achim A. Jungbluth, André L. Vettore, Gisele W.B. Colleoni

Blood (2009) 114 (22): 4887.

https://doi.org/10.1182/blood.V114.22.4887.4887

Published: 2009

Journal Articles

Differential Expression of Type I MAGE in New and Relapsed Multiple Myeloma: Evidence for Association with Proliferation and Progression of Disease.

Hearn J. Cho, MD, PhD, Scott Ely, MD, Wayne R. Austin, AB, Ruben Niesvizky, MD, Roger Pearse, MD, PhD, Morton Coleman, MD, Nina Bhardwaj, MD, PhD, Maurizio DiLiberto, PhD, Selina Chen-Kiang, PhD, Lloyd J. Old, MD, Achim A. Jungbluth, MD

Blood (2006) 108 (11): 3397.

https://doi.org/10.1182/blood.V108.11.3397.3397

Published: 2006

Journal Articles

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation

Djordje Atanackovic, Julia Arfsten, Yanran Cao, Sacha Gnjatic, Frank Schnieders, Katrin Bartels, Georgia Schilling, Christiane Faltz, Christine Wolschke, Judith Dierlamm, Gerd Ritter, Thomas Eiermann, Dieter Kurt Hossfeld, Axel R. Zander, Achim A. Jungbluth, Lloyd J. Old, Carsten Bokemeyer, Nicolaus Kröger

Blood (2006) 109 (3): 1103–1112.

https://doi.org/10.1182/blood-2006-04-014480

Published: 2006

Includes: Supplemental data

Journal Articles

Type I MAGE Proteins: Novel Markers of Proliferation in Multiple Myeloma Progenitor Cells.

Hearn J. Cho, MD, PhD, Otavia Caballero, MD, Achim A. Jungbluth, MD, Maurizio DiLiberto, PhD, Ruben Niesvizky, MD, Lloyd J. Old, MD, Selina Chen-Kiang, PhD

Blood (2005) 106 (11): 5115.

https://doi.org/10.1182/blood.V106.11.5115.5115

Published: 2005

Journal Articles

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation

Achim A. Jungbluth, Scott Ely, Maurizio DiLiberto, Ruben Niesvizky, Barbara Williamson, Denise Frosina, Yao-Tseng Chen, Nina Bhardwaj, Selina Chen-Kiang, Lloyd J. Old, Hearn Jay Cho

Blood (2005) 106 (1): 167–174.

https://doi.org/10.1182/blood-2004-12-4931

Published: 2005

NARROW

Association of MHC-II, PD-L1, and FoxP3 with Disease Status and Outcomes in Patients with Hodgkin Lymphoma

Distinctive Genomic Alterations in Testicular Diffuse Large B Cell Lymphoma

Wilms´Tumor 1 Protein Is Highly Expressed on Malignant Plasma Cells and Provides a Novel Target for Immunotherapeutic Approaches

Recombinant (rec) MAGE-A3 Protein Immunotherapy and Peripheral Blood Lymphocyte (PBL) Reconstitution Induce Strong Antigen-Specific Humoral and Cellular Immune Responses in Patients Undergoing Autologous Stem Cell Transplantation (ASCT) for Consolidation of Multiple Myeloma (MM)

MAGE-A3 Recombinant Protein (recMAGE-A3) Immunotherapy and Autologous Peripheral Blood Lymphocyte (PBL) Infusion Is Safe and Induces Robust Humoral Immune Responses In Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplantation (autoSCT)

WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell–depleted hematopoietic stem cell transplantation and donor lymphocyte infusions

WT1-Specific Immune Responses in Patients with High-Risk Multiple Myeloma Undergoing Allogeneic T Cell-Depleted Hematopoietic Stem Cell Transplantation Followed by Donor Lymphocyte Infusions

Cancer-Testis (CT) Antigen Expression In AL Amyloidosis

MAGE-A Inhibits Apoptosis In Proliferating Multiple Myeloma Cells

Expression of Cancer Testis (CT) Antigens NY-ESO-1 and LAGE-1 in Multiple Myeloma (MM): Could a Vaccine against the Former Antigen Be Effective against the Latter?

Differential Expression of Type I MAGE in New and Relapsed Multiple Myeloma: Evidence for Association with Proliferation and Progression of Disease.

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation

Type I MAGE Proteins: Novel Markers of Proliferation in Multiple Myeloma Progenitor Cells.

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only